Vijaya Diagnostic Q4 FY26: record quarter, steady margins, and a widening footprint

Q4 FY26 revenue from operations was INR 219.4 crore, EBITDA was INR 95.5 crore (43.5% margin), and PAT was INR 47.9 crore (21.8% margin).

FY26 revenue from operations was INR 814.2 crore, EBITDA was INR 336.9 crore (41.4% margin), and PAT was INR 173.0 crore (21.2% margin).

For Q4 FY26, the presentation reported pathology at 63.2% and radiology at 36.8% of revenue.

B2C revenue contribution was reported at 92% in Q4 FY26 and also 92% for FY26.

Management indicated it intends to commission 4 to 5 hubs and 10 to 12 spokes in FY27, based on executed leases, with periodic updates as additional locations are finalized.

Management indicated around INR 140 to 150 crore for FY27, including capex for new centres (4 to 5 hubs and 10 to 12 spokes), the automated lab at Panjagutta, and replacement/upgrade capex in existing centres.

Management stated it is not looking to expand into North India currently and indicated this is likely for another 3 to 5 years while focusing on densifying existing clusters.